Differences Among Older English and Spanish-speaking Latinx Patients with Type 2 Diabetes at Risk for Hypoglycemia (Admin Supp)
Differences Among Older English and Spanish-speaking Latinx Patients with Type 2 Diabetes at Risk for Hypoglycemia (Admin Supp)
批准号:
10598945
负责人:
RICHARD W GRANT
金额:
$8.14万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-08-15 至 2025-04-30
关键词:
AddressAdministrative SupplementAdultAgeAge-YearsAwardBenefits and RisksCaliforniaCaringChronicClinicalClinical TrialsCommunicationDangerousnessDecision MakingDiabetes MellitusElderlyEthnic OriginEventGoalsHealthcare SystemsHispanicHypoglycemiaLatinxMethodsNon-Insulin-Dependent Diabetes MellitusParentsParticipantPatient PreferencesPatientsPharmaceutical PreparationsPopulationPrimary Health CareProviderRaceResearchResearch DesignRiskSafetySourceTranslatingUnderrepresented MinorityUnited States National Institutes of HealthVisitVoiceWorkadverse outcomebasecomparativeexperiencehealth care disparityhealth care settingshigh riskimprovedinnovationinsightmedication safetyolder patientparent grantpatient populationpreferencerandomized trialskillstool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
Many older adults with type 2 diabetes (T2D) experience dangerous hypoglycemic due to intensive T2D
medication treatment.1,2 The decision to reduce treatment intensity must be informed by patient preferences
and values.3 New tools that educate patients and build their communication skills to voice their preferences
offer a promising strategy for improving the safety of T2D care in high-risk older adults.4,5 The goal of this R01
award is to apply principles of values elicitation and skill building for communication and decision making to the
specific clinical problem of hypoglycemia-related adverse outcomes in vulnerable older patients. The aims of
the parent R01 are to develop an online tool to specifically address T2D treatment intensity in older adults at
increased risk for hypoglycemic events, and to then conduct a randomized trial to assess the efficacy of this
new tool to reduce hypoglycemia events among high-risk patients 75 years of age. Our approach to support
value-aligned care represents an innovative and potentially widely applicable method to help older adults to
make informed decisions based on their goals and preferences.6 If successful, this framework could be scaled
and applied in a wide variety of healthcare settings and chronic conditions in which evolving risks, benefits, and
consequences of treatment require re-assessment with age. The addition of Clarissa Ferguson through this
Administrative Supplement will provide the project with the excellent opportunity to conduct analyses of older
Hispanic/Latinx participants who would otherwise be eligible for our clinical trial (approximately 29% of
expected participants, similar proportion to the source population in Northern California).7 She will examine the
similarities and unique differences in how older Hispanic/Latinx patients with type 2 diabetes versus adults
from other race/ethnicities engage with the health care system and their current medication-related practices.
Further study focused on older Hispanic/Latinx patients has the potential to provide useful insight into how to
best engage this patient population in research designed to improve engagement and reduce medication risk.8
The proposed research is directly related to the main goals of the parent grant while also broadening our
project by extending our comparative analyses of Hispanic/Latinx patients. This study addresses the three NIH
priorities of translating evidence into practice, improving medication safety, and understanding health care
disparities. The specific project proposed within the Under-Represented Minority (URM) Administrative
Supplement will focus on the examination of older Hispanic/Latinx patients with type 2 diabetes at increased
risk for hypoglycemia. This supplemental work will provide further insight into the potential disparities and
unique barriers to communication faced by older Hispanic/Latinx patients during primary care visits.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Pragmatic Clinical Trial of Continuous Glucose Monitoring-based Interventions for Safe Insulin Prescribing in High-Risk Older Patients with Type 2 Diabetes
-
批准号:10559099
-
项目类别:
-
资助金额:$61.32万
-
财政年份:2023
-
负责人:RICHARD W GRANT
-
依托单位:
Clinical Trial of Expanded Advance Care Planning to Address Regimen Intensity in Older Patients at High Risk for Treatment-Induced Hypoglycemia
-
批准号:10026740
-
项目类别:
-
资助金额:$63.43万
-
财政年份:2020
-
负责人:RICHARD W GRANT
-
依托单位:
Clinical Trial of Expanded Advance Care Planning to Address Regimen Intensity in Older Patients at High Risk for Treatment-Induced Hypoglycemia
-
批准号:10237364
-
项目类别:
-
资助金额:$67.41万
-
财政年份:2020
-
负责人:RICHARD W GRANT
-
依托单位:
Clinical Trial of Expanded Advance Care Planning to Address Regimen Intensity in Older Patients at High Risk for Treatment-Induced Hypoglycemia
-
批准号:10837668
-
项目类别:
-
资助金额:$8.88万
-
财政年份:2020
-
负责人:RICHARD W GRANT
-
依托单位:
Race/ethnic Differences Among Older Patients with Type 2 Diabetes at Risk for Hypoglycemia
-
批准号:10318875
-
项目类别:
-
资助金额:$8.87万
-
财政年份:2020
-
负责人:RICHARD W GRANT
-
依托单位:
Clinical Trial of Expanded Advance Care Planning to Address Regimen Intensity in Older Patients at High Risk for Treatment-Induced Hypoglycemia
-
批准号:10395599
-
项目类别:
-
资助金额:$57.5万
-
财政年份:2020
-
负责人:RICHARD W GRANT
-
依托单位:
Clinical Trial of Expanded Advance Care Planning to Address Regimen Intensity in Older Patients at High Risk for Treatment-Induced Hypoglycemia
-
批准号:10633067
-
项目类别:
-
资助金额:$60.89万
-
财政年份:2020
-
负责人:RICHARD W GRANT
-
依托单位:
Administrative Supplement (PA-20-272) to Expand Safe Insulin De-Prescribing (R01 Award) to include Patients with ADRD and Their Caregivers
-
批准号:10492857
-
项目类别:
-
资助金额:$29.78万
-
财政年份:2020
-
负责人:RICHARD W GRANT
-
依托单位:
Care System Analytics to Support Primary Care Patients with Complex Medical and Social Needs
-
批准号:10013216
-
项目类别:
-
资助金额:$63.27万
-
财政年份:2019
-
负责人:RICHARD W GRANT
-
依托单位:
Care System Analytics to Support Primary Care Patients with Complex Medical and Social Needs
-
批准号:10259671
-
项目类别:
-
资助金额:$62.93万
-
财政年份:2019
-
负责人:RICHARD W GRANT
-
依托单位:
T32 Training Program in Diabetes Translational Research
-
批准号:10382580
-
项目类别:
-
资助金额:$3.68万
-
财政年份:2018
-
负责人:RICHARD W GRANT
-
依托单位:
T32 Training Program in Diabetes Translational Research
-
批准号:10200217
-
项目类别:
-
资助金额:$3.62万
-
财政年份:2018
-
负责人:RICHARD W GRANT
-
依托单位:
T32 Training Program in Diabetes Translational Research
-
批准号:10442496
-
项目类别:
-
资助金额:$4.45万
-
财政年份:2018
-
负责人:RICHARD W GRANT
-
依托单位:
T32 Training Program in Diabetes Translational Research
-
批准号:10201583
-
项目类别:
-
资助金额:$15.17万
-
财政年份:2018
-
负责人:RICHARD W GRANT
-
依托单位:
T32 Training Program in Diabetes Translational Research
-
批准号:10655948
-
项目类别:
-
资助金额:$3.75万
-
财政年份:2018
-
负责人:RICHARD W GRANT
-
依托单位:
Multi-Component Behavioral Intervention for Complex Patients with CVD Risk
-
批准号:9434534
-
项目类别:
-
资助金额:$3.74万
-
财政年份:2017
-
负责人:RICHARD W GRANT
-
依托单位:
Mentored Research to Improve Care for Complex Patients with Diabetes
-
批准号:9979855
-
项目类别:
-
资助金额:$18.28万
-
财政年份:2016
-
负责人:RICHARD W GRANT
-
依托单位:
Mentored Research to Improve Care for Complex Patients with Diabetes
-
批准号:9751838
-
项目类别:
-
资助金额:$18.28万
-
财政年份:2016
-
负责人:RICHARD W GRANT
-
依托单位:
Multi-Component Behavioral Intervention for Complex Patients with CVD Risk
-
批准号:8988295
-
项目类别:
-
资助金额:$71.51万
-
财政年份:2014
-
负责人:RICHARD W GRANT
-
依托单位:
Multi-Component Behavioral Intervention for Complex Patients with CVD Risk
-
批准号:8629574
-
项目类别:
-
资助金额:$63.61万
-
财政年份:2014
-
负责人:RICHARD W GRANT
-
依托单位:
海外基金